Brief #64—Health
By Taylor J Smith
Health & Gender
Purdue Pharmaceuticals Turbulent Dealings with the Opioid Crisis
Brief #62—Health
By Taylor J Smith
The Administration Joins Others in Concern Regarding E-Cigarettes and Vaping
Brief #63—Healthcare
By Taylor J Smith
Landmark Decision in Opioid Epidemic Case
Brief #61—Health
ByTaylorJ Smith
Trump Administration Threatens to Make Big Changes to SNAP Benefits
Brief #60—Healthcare
By Taylor J Smith
The Trump Administration Defunds UNFPA for a Third Consecutive Year
Brief #59—Health
By Taylor J Smith
States Have a Mixed Response in Dealing with a Nation-wide Measles Outbreak
Brief #58—Health
By Taylor J Smith
New Changes to Health Care Rights Law Threaten Transgender and Nonbinary Communities
Brief #57—Health Policy
By Taylor J Smith
Trump Administration Proposes New Faith-Based Protections for Health-care Providers
Brief #56—Healthcare
By Taylor J Smith
Fetal Heartbeat Bills are Mounting Against Women’s Reproductive Rights
Brief #36—Health
By Taylor J Smith
2020 Budget Proposal Slashes Funding for Medicaid and Medicare
Brief #54—Healthcare
By Taylor J Smith
In early March, the Trump administration announced the 2020 budget proposal with controversial cuts.
EPA Finally Vows to Regulate Cancer Causing Toxins
Brief #53—Health
By Taylor J Smith
After persistent national outcry, the EPA has announced it will regulate a group of long-lasting chemicals, called polyfluoroalkyl and perfluoroalkyl substances (PFAS), which have been linked to reproductive and developmental, liver and kidney, and immunological effects.